Focus Groups to Determine Surrogates Views Regarding Patient Preference Predictors
2 other identifiers
observational
27
1 country
2
Brief Summary
Background: Some people cannot make medical treatment decisions on their own. The people who make decisions on their behalf are called medical surrogates. Sometimes surrogates cannot predict which treatment course the person or their loved ones would have chosen. The surrogates often become distressed because of making these decisions. Researchers think a tool called a Patient Preference Predictor (PPP) may be able to make the process easier. The PPP would predict what treatment the person would want. This is based on treatment preferences of similar people in a similar circumstance. Researchers want to interview surrogates to explore their views on the PPP. Objective: To explore surrogates views on incorporating a PPP into shared medical decision-making. Eligibility: People 18 years or older who: Have acted as a surrogate medical decision-maker within the past 3 years. This includes decisions about treatment, medication, hospice care, hospital admission, or discharge. Are not pregnant Design: Participants will be screened by meeting with clinicians in person or by phone to discuss the study. Participants will take part in a focus group. This is a small group of people discussing their thoughts and opinions. This will last for about 2 hours. Participants will be served a light meal. Participants will provide information about themselves and their views. They will talk about their past experiences making medical decisions for someone. They will discuss how they felt about these decisions. The PPP will be explained to participants. They will give their views on it. The research team will audio record the focus group and take notes. Participants will fill out questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2016
CompletedFirst Posted
Study publicly available on registry
September 13, 2016
CompletedStudy Start
First participant enrolled
December 31, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2020
CompletedOctober 29, 2024
October 1, 2024
1.1 years
September 10, 2016
October 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Views of participants on PPP
Level of acceptance regarding Patient Preference Predictor (PPP)
Prior to, during, and immediately following the focus group session
Secondary Outcomes (1)
Views of Participants on PPP as patients
Prior to, during, and immediately following the focus group
Study Arms (1)
1/Patient Surrogates
Any eligible participant who have acted as a surrogate medical decision-maker.
Eligibility Criteria
Any individual who acted as a surrogate decision maker for individuals undergoing any treatment.
You may qualify if:
- years or older
- Experience making at least one medical decision on behalf of an incompetent patient within the past 3 years. A medical decision for the purposes of this study is defined as making a decision in a context in which there was more than 1 feasible or reasonable option.
- Ability to provide informed consent
You may not qualify if:
- Inability to speak, understand, or read English
- The patient on behalf of whom the individual acted as surrogate is deceased for less than two months.
- In the view of the referring clinician, participation in the study is deemed excessively burdensome.
- Candidate for study is pregnant
- Court appointed surrogate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
St. Elizabeths Hospital
Washington D.C., District of Columbia, 20032, United States
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Publications (3)
Shalowitz DI, Garrett-Mayer E, Wendler D. How should treatment decisions be made for incapacitated patients, and why? PLoS Med. 2007 Mar;4(3):e35. doi: 10.1371/journal.pmed.0040035. No abstract available.
PMID: 17388655BACKGROUNDRid A, Wendler D. Use of a patient preference predictor to help make medical decisions for incapacitated patients. J Med Philos. 2014 Apr;39(2):104-29. doi: 10.1093/jmp/jhu001. Epub 2014 Feb 13.
PMID: 24526785BACKGROUNDRid A, Wesley R, Pavlick M, Maynard S, Roth K, Wendler D. Patients' priorities for treatment decision making during periods of incapacity: quantitative survey. Palliat Support Care. 2015 Oct;13(5):1165-83. doi: 10.1017/S1478951514001096. Epub 2014 Oct 2.
PMID: 25273677BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
David Wendler, Ph.D.
National Institutes of Health Clinical Center (CC)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2016
First Posted
September 13, 2016
Study Start
December 31, 2018
Primary Completion
February 20, 2020
Study Completion
July 21, 2020
Last Updated
October 29, 2024
Record last verified: 2024-10